Streetbeat News

Products Services

ACN

Accenture has launched a new solution on Salesforce that utilizes data and artificial intelligence to create personalized experiences. This development highlights Accenture's focus on integrating advanced technologies to enhance customer engagement.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 12:02 pm

STOK

Stoke Therapeutics presented promising data on zorevunersen, showing significant seizure reduction and cognitive improvements in Dravet syndrome patients. The data supports plans for a Phase 3 study.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 12:00 pm

ASNS

Actelis Networks shares rose following the announcement of a new order from a major aerial transportation agency.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 11:56 am

BCTX

BriaCell Therapeutics received positive feedback from the FDA for its Bria-PROS+ prostate cancer treatment, simplifying its development pathway by waiving certain study requirements. This also supports the development of other cancer treatments in its pipeline.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 11:54 am

POET

POET Technologies has been selected by Mentech Technology to supply optical engines for 800G and 1.6T modules, marking a significant development in their business relationship.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 11:54 am

CNTA

ORCL

VRDN

Oracle shares rose 9% after strong Q1 results and an upgrade by JMP Securities. Viridian Therapeutics saw a 16% increase following positive phase 3 trial data for VRDN-001. Centessa Pharmaceuticals' stock jumped 18% due to promising interim data from a phase 1 trial of ORX750.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 11:52 am

BMR

NVDA

Beamr is set to showcase its 4K live streaming optimization technology using NVIDIA Holoscan at the IBC 2024 event. This demonstration highlights Beamr's advancements in video optimization, potentially impacting the media streaming industry.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 11:51 am

VSTM

Verastem Oncology is set to present a late-breaking abstract of mature data from its ongoing Phase 2 RAMP 201 clinical trial at the IGCS Annual Meeting. This presentation could provide significant insights into the trial's progress and potential implications for Verastem's future developments.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 11:50 am

DBCCF

Decibel Cannabis Company Inc. reported a 400% growth in its dried flower market and announced expansion plans to the UK, Australia, Israel, and Germany. Despite a recent drop in domestic sales, the company is focusing on operational efficiencies and new product strategies to improve cash flow and reduce debt.

Portfolio Pulse from Nina Zdinjak

September 10, 2024 | 11:50 am

BYSI

BeyondSpring presented final Phase 3 results for Plinabulin in 2L/3L NSCLC at ISLAC 2024, showing significant efficacy and safety improvements over Docetaxel. The study demonstrated improved overall survival, progression-free survival, and reduced severe neutropenia.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 11:44 am